Adelle S. Jee
YOU?
Author Swipe
View article: Pharmaco-economic Inequalities in Access to Antifibrotic Treatment for Interstitial Lung Disease in the Asia-Pacific Region
Pharmaco-economic Inequalities in Access to Antifibrotic Treatment for Interstitial Lung Disease in the Asia-Pacific Region Open
Antifibrotic drugs, available for the best part of the last decade in many parts of the world, have improved outcomes in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. However, it is unclear whether patient…
View article: Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis
Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis Open
Objectives To investigate the prognostic utility of 28 serum biomarkers in systemic sclerosis (SSc), SSc-associated interstitial lung disease (SSc-ILD) and clinically relevant disease subgroups. Methods Participants with sera, high-resolut…
View article: A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis–Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study
A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis–Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study Open
Objective In patients with systemic sclerosis (SSc), we investigated composite serum biomarker panels for the diagnosis and risk stratification of SSc–associated interstitial lung disease (SSc‐ILD). Methods We analyzed 28 biomarkers in 640…
View article: Delays in idiopathic pulmonary fibrosis diagnosis and treatment: Time for change
Delays in idiopathic pulmonary fibrosis diagnosis and treatment: Time for change Open
See related article
View article: Nailfold capillaroscopy by smartphone-dermatoscope for connective tissue disease diagnosis in interstitial lung disease: a prospective observational study
Nailfold capillaroscopy by smartphone-dermatoscope for connective tissue disease diagnosis in interstitial lung disease: a prospective observational study Open
Nailfold capillaroscopy (NFC) is a non-invasive tool validated for systemic sclerosis diagnosis. The role and interpretation of NFC in interstitial lung disease (ILD) patients for the diagnosis of connective tissue disease associated ILD (…
View article: Supplementary Material for: Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort
Supplementary Material for: Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort Open
Background and objective: The research term “interstitial pneumonia with autoimmune features” (IPAF) encompasses interstitial lung disease (ILD) patients with autoimmune features not meeting diagnostic criteria for a defined connective tis…
View article: Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*
Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand* Open
Pulmonary complications in CTD are common and can involve the interstitium, airways, pleura and pulmonary vasculature. ILD can occur in all CTD (CTD‐ILD), and may vary from limited, non‐progressive lung involvement, to fulminant, life‐thre…
View article: Australasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective database
Australasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective database Open
Background Interstitial Lung Disease (ILD) is a group of respiratory conditions affecting the lung interstitium often associated with progressive respiratory failure. There is increasing recognition of the need for improved epidemiological…
View article: Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD)
Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD) Open
Interstitial lung disease (ILD) can be associated with all connective tissue diseases and is an important cause of morbidity and mortality. The management of connective tissue disease-interstitial lung disease (CTD-ILD) is challenging due …
View article: Hypersensitivity pneumonitis: <scp>A</scp> protean and challenging disease
Hypersensitivity pneumonitis: <span>A</span> protean and challenging disease Open
See related Article
View article: Automated quality control of forced oscillation measurements: respiratory artifact detection with advanced feature extraction
Automated quality control of forced oscillation measurements: respiratory artifact detection with advanced feature extraction Open
The forced oscillation technique (FOT) can provide unique and clinically relevant lung function information with little cooperation with subjects. However, FOT has higher variability than spirometry, possibly because strategies for quality…
View article: Year in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep
Year in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep Open
Adelle S. Jee and Tamera J. Corte The year 2016 has been pivotal for researchers and clinicians with an interest in interstitial lung disease (ILD). The advent of anti-fibrotic therapy for idiopathic pulmonary fibrosis (IPF), the most comm…
View article: Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF) Open
The diagnosis of interstitial lung disease (ILD) requires meticulous evaluation for an underlying connective tissue disease (CTD), with major implications for prognosis and management. CTD associated ILD (CTD-ILD) occurs most commonly in t…
View article: A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria
A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria Open
We commend Oldham et al . [1] for their recent article using the new European Respiratory Society/American Thoracic Society criteria for interstitial pneumonia with autoimmune features (IPAF) to re-characterise a cohort of interstitial lun…